🇺🇸 varicella zoster virus in United States
590 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 590
Most-reported reactions
- Off Label Use — 94 reports (15.93%)
- Drug Ineffective — 77 reports (13.05%)
- Fatigue — 74 reports (12.54%)
- Arthralgia — 60 reports (10.17%)
- Cough — 52 reports (8.81%)
- Condition Aggravated — 50 reports (8.47%)
- Pain In Extremity — 48 reports (8.14%)
- Blood Pressure Increased — 46 reports (7.8%)
- Pyrexia — 45 reports (7.63%)
- Diarrhoea — 44 reports (7.46%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is varicella zoster virus approved in United States?
varicella zoster virus does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for varicella zoster virus in United States?
AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.